4,576
Participants
Start Date
April 26, 2018
Primary Completion Date
February 4, 2023
Study Completion Date
February 4, 2023
3 months dual anti-platelet therapy
Patients with acute coronary syndrome will be randomised to 3 months dual anti-platelet therapy.
12 months dual anti-platelet therapy
Patients with acute coronary syndrome will be randomised to 12 months dual anti-platelet therapy.
Edinburgh Royal Infirmary, Edinburgh
British Heart Foundation
OTHER
University of Edinburgh
OTHER